Skip to main content
Global Arbitration, Trade and Advocacy Update

Buy (More) American: Final Rule Falls Short of Previewed Changes But Still Has Major Implications for Life Sciences and Other Companies

March 28, 2022

On March 7, 2022, the U.S. Department of Defense (DOD), General Services Administration, and National Aeronautics and Space Administration (collectively, the Government) issued an important final rule amending the Buy American Act (BAA) requirements in the Federal Acquisition Regulation (FAR), which will go into effect on October 25, 2022.1 Although the final rule implements some of the proposals first seen in a proposed rule on the same subject published on July 31, 2021, the final rule acknowledges that it leaves much undone. Therefore, we should expect to see more changes — though, even then, all of the considerations highlighted in last year’s proposed rule may not see the light of day for some time, if ever.

The July 30, 2021, proposed rule, in furtherance of President Joe Biden’s January 25, 2021, executive order2 to encourage the use of federal procurements to support American businesses and workers, was intended to significantly strengthen the BAA requirements in the FAR.3 Sidley previously addressed this proposal in detail

The BAA is a standard FAR provision found in many agency procurements, including procurements of pharmaceuticals and medical devices. It is normal for such procurements above the micropurchase threshold of $10,000 to contain either a BAA clause or a Trade Agreements Act (TAA) clause, also discussed below, and each of these clauses establishes country of origin requirements that can strongly affect the Government’s contract award decisions. Consequently, it is important for life sciences companies to understand what will be changing and what will remain the same, at least for the present, regarding these clauses.

To best understand what aspects of the BAA remain as they have been and what are changed, this Alert first addresses the key elements that remain the same.

弁護士広告—Sidley Austin LLP はグローバルな法律事務所です。当事務所の所在地および連絡先情報は、www.sidley.com/en/locations/offices に掲載されています。

Sidley は、本情報をクライアントおよび関係者の皆様へのサービスとして、教育目的のみに提供しています。本情報は、法的助言として解釈または依拠されるべきものではなく、また弁護士と依頼者の関係を生じさせるものでもありません。読者は、専門家の助言を求めることなく本情報に基づいて行動すべきではありません。Sidley および Sidley Austin とは、www.sidley.com/disclaimer に記載のとおり、Sidley Austin LLP およびその関連パートナーシップを指します。

© Sidley Austin LLP

お問い合わせ

この Sidley Update に関してご質問がある場合は、通常ご担当されている Sidley の弁護士、またはご連絡ください。